June 27, 2017 1:40 AM ET

Life Sciences Tools and Services

Company Overview of Shasun Pharmaceuticals Ltd

Company Overview

Shasun Pharmaceuticals Limited manufactures and sells active pharmaceutical ingredients (APIs), intermediates, and formulations to the pharmaceutical industry primarily in India. The company offers API products in the areas of pain management and musculoskeletal, central nervous system, cardiovascular, hyperphosphataemia, COPD, anti-infective, gastrointestinal, gastrointestinal, cough suppressants, and anti-emetic. It also engages in the contract research and manufacturing services business, which provides chemistry and analytical services; and offers formulation development and manufacturing services for solid dosage products to pharmaceutical customers. In addition, it offers enteric coati...

Batra Centre

3rd & 4th Floor

28, Sardar Patel Road


Chennai,  600032


Founded in 1976


91 44 4344 6700


91 44 2235 0278

Key Executives for Shasun Pharmaceuticals Ltd

Chief Executive Officer, Managing Director and Whole-Time Director
Age: 63
Chief Financial Officer
Director of Operations & EHS and Whole Time Director
Age: 54
President of Biotech Unit & Synthetic R&D
President of Formulation
Compensation as of Fiscal Year 2016.

Shasun Pharmaceuticals Ltd Key Developments

Strides Shasun Ltd Announces Unaudited Standalone and Consolidated Earnings Results for the Third Quarter Ended December 31, 2015

Strides Shasun Ltd. announced unaudited Standalone and consolidated earnings results for the third quarter ended December 31, 2015. The company has posted a net profit of INR 440.856 million for the quarter ended December 31, 2015. Total income is INR 10,913.711 million for the quarter ended December 31, 2015. The group has posted a net profit after taxes, minority interest and share of profit of associates of INR 518.639 million for the quarter ended December 31, 2015. Total income is INR 15,283.845 million for the quarter ended December 31, 2015.

Shasun Pharmaceuticals Ltd(BSE:524552) dropped from S&P Global BMI Index

Shasun Pharmaceuticals Ltd(BSE:524552) dropped from S&P Global BMI Index

Shasun Pharmaceuticals Forced to Close Tamil Nadu Pharmaceutical Factory Following Fire

Shasun Pharmaceuticals has announced that government authorities have requested the company to suspend production at its active pharmaceutical ingredient (API) manufacturing facility in Cuddalore, Tamil Nadu. The measure follows the outbreak of a fire at a new block at the factory during testing. Shasun reported that one factory worker was killed in the fire, while another suffered injuries and was hospitalized.

Recent Private Companies Transactions

No transactions available in the past 12 months.

The information and data displayed in this profile are created and managed by S&P Global Market Intelligence, a division of S&P Global. Bloomberg.com does not create or control the content. For inquiries, please contact S&P Global Market Intelligence directly by clicking here.

Stock Quotes

Market data is delayed at least 15 minutes.

Company Lookup

Most Searched Private Companies

Company Name Geographic Region
Lawyers Committee for Civil Rights Under Law United States
NYC2012, Inc. United States
Bertelsmann AG Europe
The Advertising Council, Inc. United States
Rush University United States

Sponsored Financial Commentaries

Sponsored Links

Request Profile Update

Only a company representative may request an update for the company profile. Documentation will be required.

To contact Shasun Pharmaceuticals Ltd, please visit www.shasun.com. Company data is provided by S&P Global Market Intelligence. Please use this form to report any data issues.

Please enter your information in the following field(s):
Update Needed*

All data changes require verification from public sources. Please include the correct value or values and a source where we can verify.

Your requested update has been submitted

Our data partners will research the update request and update the information on this page if necessary. Research and follow-up could take several weeks. If you have questions, you can contact them at bwwebmaster@businessweek.com.